.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Accenture
McKesson
Fish and Richardson
Federal Trade Commission
Fuji
Deloitte
Colorcon
US Army
Farmers Insurance

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021146

« Back to Dashboard
NDA 021146 describes ATROPINE SULFATE ANSYR PLASTIC SYRINGE, which is a drug marketed by Hospira and is included in one NDA. It is available from two suppliers. Additional details are available on the ATROPINE SULFATE ANSYR PLASTIC SYRINGE profile page.

The generic ingredient in ATROPINE SULFATE ANSYR PLASTIC SYRINGE is atropine sulfate. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.

Summary for NDA: 021146

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 021146

Suppliers and Packaging for NDA: 021146

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATROPINE SULFATE ANSYR PLASTIC SYRINGE
atropine sulfate
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 021146 NDA Hospira, Inc. 0409-1630 0409-1630-10 10 CARTON in 1 PACKAGE (0409-1630-10) > 1 SYRINGE, PLASTIC in 1 CARTON > 10 mL in 1 SYRINGE, PLASTIC
ATROPINE SULFATE ANSYR PLASTIC SYRINGE
atropine sulfate
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 021146 NDA Hospira, Inc. 0409-9629 0409-9629-05 10 CARTON in 1 PACKAGE (0409-9629-05) > 1 SYRINGE, PLASTIC in 1 CARTON > 5 mL in 1 SYRINGE, PLASTIC

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSStrength0.1MG/ML
Approval Date:Jul 9, 2001TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSStrength0.05MG/ML
Approval Date:Jul 9, 2001TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Fish and Richardson
AstraZeneca
McKesson
Farmers Insurance
Boehringer Ingelheim
Cantor Fitzgerald
Covington
US Department of Justice
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot